Chronic dosing with MLN0518 (Tandutinib), a small molecule PDGFR alpha/beta inhibitor, reduces tumor growth, hypoxia, and perfusion in 06 glioma xenografts: An investigation using immunohistochemical and MRI methods

Boult, JKR; Walker-Samuel, S; Bradley, DP; Robinson, SP; (2009) Chronic dosing with MLN0518 (Tandutinib), a small molecule PDGFR alpha/beta inhibitor, reduces tumor growth, hypoxia, and perfusion in 06 glioma xenografts: An investigation using immunohistochemical and MRI methods. In: AMER ASSOC CANCER RESEARCH

http://ift.tt/2zG1RUY